Fast Five Quiz: How Much Do You Know About 'Broken-Heart Syndrome'?

Yasmine S. Ali, MD, MSCI

Disclosures

January 22, 2018

Patients who are found to have LV thrombus, which occurs in 5% of patients with Takotsubo cardiomyopathy, require anticoagulation. Treatment options are largely empiric and supportive; however, when hemodynamics permit, beta-blockers seem to be helpful.

Close follow-up care with a cardiologist in the weeks after diagnosis is recommended for patients with Takotsubo cardiomyopathy to ensure resolution of the cardiomyopathy, usually with serial echocardiograms. Thereafter, annual clinical follow-up is advised, because the long-term effects and natural history of Takotsubo cardiomyopathy are unknown.

Although thrombolytics do not benefit patients with Takotsubo cardiomyopathy, their use should not be withheld when percutaneous coronary intervention (PCI) is not available and patients otherwise meet criteria.

For more on the treatment of Takotsubo cardiomyopathy, read here.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....